SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-21-328063
Filing Date
2021-11-12
Accepted
2021-11-12 16:07:06
Documents
2
Group Members
ANSBERT GADICKEEDWARD HURWITZLUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV2014 LLCMPM ASSET MANAGEMENT INVESTORS BV2018 LLCMPM BIOVENTURES 2014 (B), L.P.MPM BIOVENTURES 2014 GP LLCMPM BIOVENTURES 2014 LLCMPM BIOVENTURES 2018 (B), L.P.MPM BIOVENTURES 2018 GP

Document Format Files

Seq Description Document Type Size
1 SC 13D d255955dsc13d.htm SC 13D 305655
2 EX-99.C d255955dex99c.htm EX-99.C 20493
  Complete submission text file 0001193125-21-328063.txt   328280
Mailing Address C/O MPM ASSET MANAGEMENT LLC 450 KENDALL STREET CAMBRIDGE MA 02142
Business Address C/O MPM ASSET MANAGEMENT LLC 450 KENDALL STREET CAMBRIDGE MA 02142 (617) 425-9200
MPM BioVentures 2014, L.P. (Filed by) CIK: 0001609492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 6 TIDE STREET BOSTON MA 02210
Business Address 6 TIDE STREET BOSTON MA 02210 857-305-1825
Entrada Therapeutics, Inc. (Subject) CIK: 0001689375 (see all company filings)

IRS No.: 813983399 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-93025 | Film No.: 211403442
SIC: 2834 Pharmaceutical Preparations